May 22, 2019
8:50am – 5pm
Biomedical Research Center – Atrium
Johns Hopkins Bayview Campus
251 Bayview Blvd. Baltumore, MD 21224
Organizers: Yavin Shaham, David Epstein, Kenzie Preston, Amy Newman
The one-day symposium will feature intramural and extramural speakers who will discuss recent advances in research and treatment for opioid use disorders.
Schedule
Amy Newman – 8:50 – Introduction to symposium
Morning Session (extramural)
Chris Evans – 9:00 – Targeting negative affect for treatment of pain & addiction
Charlie Chavkin – 9:25 – Kappa antagonists as therapeutics for opioid addiction
Nurulain Zaveri – 9:50 – NOP-MOP agonists for pain and addiction treatment
Coffee Break – 10:15
Matt Banks – 10:45 – A preclinical algorithm for evaluating novel OUD medications
Sandra Comer – 11:10 – OUD medication development: Do pre-clinical & clinical data align?
Ken Silverman – 11:35 – Therapeutic workplace to address poverty and opioid addiction
Diana Martinez – 12:00 – Discussant
Lunch break plus poster session – 12:15
Afternoon Session (intramural)
Sergi Ferre – 1:30 – Opioid-galanin heteromers determine opioid dopaminergic effects
Leandro Vendruscolo – 1:55 – Heroin addiction engages brain stress systems
Chloe Jordan – 2:20 – D3 antagonists decrease opioid reward and increase analgesia
Coffee Break – 2:45
Jennifer Bossert – 3:15 – A rat model of opioid agonist maintenance therapy
Kenzie Preston – 3:40 – Clonidine for relapse prevention: from rat models to community
David Epstein – 4:05 – What’s odd about OUD: Translational issues unique to opioids
Rita Valentino – 4:30 – Discussant
Wilson Compton – 4:45 – Concluding Remarks
